FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, namely to otolaryngology, and can be used for the treatment of nasal polyposis. In the invention, the methods comprise administering to a subject in need thereof a pharmaceutical composition comprising an anti-IL-4R antibody or antigen-binding fragment thereof that specifically binds interleukin-4 receptors (IL-4R).
EFFECT: use of inventions allows to treat nasal polyposis by reducing biomarkers associated with T-helper cell-2 driven inflammation.
23 cl, 16 tbl, 1 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF TREATING CHRONIC SINUSITIS WITH NASAL POLYPS BY ADMINISTERING IL-4R ANTAGONIST | 2015 |
|
RU2734490C2 |
| METHODS OF TREATING OR PREVENTING ASTHMA BY ADMINISTERING IL-4R ANTAGONIST | 2015 |
|
RU2713406C2 |
| METHODS FOR TREATMENT OR PREVENTION OF ASTHMA BY ADMINISTERING IL-4R ANTAGONIST | 2013 |
|
RU2690675C2 |
| METHODS FOR TREATMENT OR PREVENTION OF ASTHMA BY ADMINISTRATION OF IL-4R ANTAGONIST | 2018 |
|
RU2793745C2 |
| METHOD OF TREATING SKIN INFECTION BY ADMINISTERING ANTAGONIST IL-4R | 2015 |
|
RU2704999C2 |
| METHODS OF TREATMENT OR PREVENTION OF ASTHMA THROUGH ADMINISTRATION OF IL-4R ANTAGONIST | 2013 |
|
RU2801531C2 |
| METHODS OF TREATING ATOPIC DERMATITIS WITH THE HELP OF IL-4R ANTAGONIST | 2013 |
|
RU2698907C2 |
| METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING IL-4R ANTAGONIST | 2013 |
|
RU2666630C2 |
| METHODS FOR INCREASING VACCINE EFFICIENCY BY INJECTING IL-4R ANTAGONIST | 2017 |
|
RU2753869C2 |
| METHODS FOR TREATING SEVERE ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR | 2017 |
|
RU2759630C2 |
